COVID-19 IgM/IgG Rapid TestKit Medical and Home Use with different certificate(CE or FDA or TGA or ANVISA or CFDA)

The rapid test strip is produced by a large listed medical company, many top scientists and laboratory technology leaders at home and abroad. COVID-19D nucleic acid product is the first product to obtain the first batch of medical device registration certificate (CFDA) in China. Antibody products are also actively applying for CFDA and have been rated as the leading company in research and development investment in China. Members of the Joint Committee on International Medical Traceability (JCTLM) and the European Standards Committee (IRMM) have won the title of China's "National Enterprise Technology Center", participated in China's "863" program many times, and designated contractors for China's provincial technology research and development work many times.

Antibody characteristics:

Dehulling antibody, target concentration, accuracy and stability, quality assurance, novel technology, light transportation, low freight, large output, flexible payment (cash and letter of credit).